PUBLISHER: The Business Research Company | PRODUCT CODE: 2133564
PUBLISHER: The Business Research Company | PRODUCT CODE: 2133564
Cannabigerol (CBG) gummies are edible products containing cannabigerol, a cannabinoid naturally present in the cannabis plant. CBG gummies generally contain a predetermined amount of CBG extract combined with other ingredients to provide a flavorful and convenient method of consuming CBG. These products are commonly used by individuals interested in the potential health effects of CBG, including its possible anti-inflammatory, neuroprotective, and mood-regulating properties.
The primary categories of cannabigerol (CBG) gummies include cannabidiol (CBD) edibles, cannabigerol (CBG), and cannabinol (CBN). Cannabidiol edibles are food products formulated with cannabidiol, a compound obtained from the cannabis plant, and are commonly consumed for its potential therapeutic properties. The available gummy flavors include raspberry juice, strawberry juice, cherry juice, strawberry puree, raspberry powder, and others, offered in hard candy and soft candy formats.
Tariffs are influencing the cannabigerol gummies market by increasing the costs of imported hemp extracts, gelatin alternatives, flavoring ingredients, packaging materials, and processing equipment. Manufacturers in North America and Europe are particularly affected because of their dependence on cross-border supplies of cannabinoid inputs, while Asia-Pacific is experiencing higher costs for imported packaging materials and ingredients. These tariffs are increasing product prices and creating scalability challenges for smaller brands. However, they are also encouraging domestic hemp cultivation, local extraction capabilities, and vertically integrated cannabinoid supply chains.
The cannabigerol (CBG) gummies market research report is one of a series of new reports from The Business Research Company that provides cannabigerol (CBG) gummies market statistics, including cannabigerol (CBG) gummies industry global market size, regional shares, competitors with a cannabigerol (CBG) gummies market share, detailed cannabigerol (CBG) gummies market segments, market trends and opportunities, and any further data you may need to thrive in the cannabigerol (CBG) gummies industry. This cannabigerol (CBG) gummies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cannabigerol (cbg) gummies market size has grown exponentially in recent years. It will grow from $0.21 billion in 2025 to $0.26 billion in 2026 at a compound annual growth rate (CAGR) of 22.7%. The expansion during the historical period can be attributed to growing consumer interest in alternative wellness solutions, expansion of legally permitted cannabinoid markets, increasing awareness and interest in minor cannabinoids, rising consumption of cannabinoid-based edible products, and advancements in cannabinoid extraction technologies.
The cannabigerol (cbg) gummies market size is expected to see rapid growth in the next few years. It will grow to $0.53 billion in 2030 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to increasing demand for targeted health and wellness solutions, expansion of regulated cannabis markets, growing emphasis on product transparency and accurate labeling, rising investment in cannabinoid research, and increasing consumer preference for gummies as a convenient delivery format. Major trends in the forecast period include growing demand for functional cannabinoid edibles, rising popularity of non-psychoactive wellness products, expansion of flavor-enhanced CBG gummies, increasing emphasis on accurate and consistent dosage formats, and greater focus on naturally sourced ingredients.
The increasing prevalence of anxiety is expected to drive the growth of the cannabigerol (CBG) gummies market. Anxiety is a psychological condition involving persistent or excessive feelings of worry, fear, and nervousness, which can also be accompanied by physical symptoms such as sweating and heart palpitations. The prevalence of anxiety is rising due to factors including stress, traumatic experiences, genetic influences, and environmental conditions. Cannabigerol (CBG) gummies are marketed for anxiety because CBG may interact with the endocannabinoid system and influence neurotransmitter activity, potentially supporting relaxation and stress management. For instance, in February 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 2,261,100 Australian males, equivalent to 23% of the male population, and 3,429,300 females, equivalent to 34% of the female population, aged 16 to 85 had experienced an anxiety disorder at some point in their lives. Therefore, the increasing prevalence of anxiety is expected to propel the growth of the cannabigerol (CBG) gummies market.
Key companies operating in the cannabigerol (CBG) gummies market are developing innovative products, such as gummies formulated with natural ingredients, to address the growing demand for wellness-focused cannabinoid products. Gummies with natural ingredients are products manufactured using organic and plant-based components, providing a wholesome and pure consumption experience. For example, in November 2023, Rare Cannabinoid Company, a health and wellness company, launched THC + CBG Relief Gummies, a distinctive combination of Delta-9-THC, CBG, and CBD designed to naturally support physical well-being. These gummies combine the benefits of THC Gummies and CBG Gummies with the complementary benefits of CBD. Each green apple-flavored gummy contains 2.5mg of Delta-9-THC, 30mg of CBG, and 10mg of CBD. With 30 gummies included in each bottle, the product provides a convenient and enjoyable option for consumers seeking to explore the potential benefits of these cannabinoids.
In October 2024, Canopy Growth, a Canada-based cannabis company, acquired Wana for an undisclosed amount. Through this acquisition, Canopy USA aims to reinforce its position as a leading brand-oriented cannabis company in the U.S. while broadening its product portfolio across state-legal cannabis markets and hemp-derived products. Wana is a U.S.-based cannabis company focused on developing innovative edible and ready-to-drink hemp-derived products, including Delta-9-THC and non-intoxicating CBD gummies.
Major companies operating in the cannabigerol (cbg) gummies market are Demetrix Inc., Rare Cannabinoid Company, CanniLabs, Vida Optima LLC, Curaleaf Holding Inc., The Cronos Group, Charlotte's Web Holdings Inc., Hemptown USA Inc., Green Roads LLC, Lazarus Naturals Inc., Medterra CBD LLC, ENDOCA, Extract Labs, NuLeaf Naturals LLC, Isodiol International Inc., CBDistillery, Elixinol Wellness Ltd., Joy Organics, CBD American Shaman, Steves Goods, Incredibles Edibles, Sunday Scaries, CannaCare Health GmbH, FAB Nutrition LLC (FAB CBD)
North America was the largest region in the cannabigerol (CBG) gummies market in 2025. The regions covered in the cannabigerol (cbg) gummies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cannabigerol (cbg) gummies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cannabigerol (CBG) gummies market consists of sales of pure CBG gummies, broad spectrum CBG gummies, full spectrum CBG gummies, isolate CBG gummies, and CBG-infused gummies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cannabigerol (CBG) Gummies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cannabigerol (cbg) gummies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cannabigerol (cbg) gummies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cannabigerol (cbg) gummies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.